Annual report pursuant to Section 13 and 15(d)

Income Taxes (Tables)

v3.22.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
Schedule of Effective Income Tax Rate Reconciliation
               
    2021   2020
Tax benefit at the Federal statutory rate     21.0 %     21.0 %
State tax, net of Federal benefit     7.0 %     6.6 %
R&D credits     5.0 %      
Permanent differences     1.0 %     9.5 %
Change in valuation allowance     (34.0 )%     (37.1 )%
Effective income tax rate     0 %     0 %
Schedule Of Deferred Tax Assets
               
    December 31,
    2021   2020
         
Deferred taxes assets:                
Net operating loss carryforward   $ 1,365,000     $ 526,000  
Stock compensation expense     463,000       166,000  
Depreciation     16,000         
R&D Credit     217,000       64,000  
                 
Total deferred tax assets     2,061,000       756,000  
Valuation allowance     (2,061,000 )     (756,000 )
                 
Deferred tax asset, net of valuation allowance   $     $